AlphaLeads | Financial AI frontrunner Xuntu Technology (AlphaPai) closes nearly RMB 200 million Series A led by Qiming Venture Partners
Pioneer in Financial AI
In March 2026, Xuntuo Technology (AlphaPai) officially completed its nearly RMB 200 million Series A funding round, co-led by Qiming Venture Partners. Following its over RMB 100 million Pre-A round last October, Xuntuo secured backing from top-tier institutions again within just five months. This round brought together a diverse mix of leading VCs and strategic investors, not only validating Xuntuo Technology's scarce value in the financial AI track but also injecting dual momentum for endogenous growth and ecosystem expansion.
Serving 80,000 Research Professionals, Evolving from Efficiency Tool to "AI Research Analyst"
As a pioneer in financial AI, Xuntuo Technology focuses on core investment research operations. Its flagship product AlphaPai, guided by the philosophy of "doing 1,000 small things to 95% excellence," was among the first to run the full commercialization loop for AI, achieving a leap in institutional research efficiency. To date, AlphaPai has cumulatively served over 80,000 research professionals across more than 6,000 institutions, with a 90% penetration rate among top-tier firms, establishing a sustained first-mover advantage.
Benefiting from continuous breakthroughs in large language models and agent technology, AlphaPai has evolved comprehensively from a single-purpose efficiency tool into an "AI research analyst" that understands both the business and its users, unleashing strong growth momentum. In 2025, human-AI interaction volume for AlphaPai's AI agent applications grew exponentially, with clear signals of shifting industry research habits, marking AlphaPai's steady progression toward becoming the next-generation entry point for investment research. Building on this foundation, AlphaPai is poised for another product leap, inaugurating a new paradigm of human-machine collaboration. As AI capabilities continue to strengthen and spill over, AlphaPai's customer base is also accelerating into broader financial scenarios including primary markets, banking, and insurance, opening up vast new market space — together forming the underlying logic for capital markets' sustained confidence and investment.
Building the Agent Industry Ecosystem with Strategic Partners, Accelerating Transformation Through Vertical and Horizontal Linkages
Xuntuo Technology founder Luodan Li said: "We've always been technological optimists. We believe AI's arrival isn't about replacing people, but about comprehensively reshaping and amplifying human value. AI cannot exist without people; AI companies must evolve in tandem with traditional institutions; vertical AI must integrate and develop with platform entry points."
Based on this conviction, Xuntuo Technology is advancing its Agent ecosystem co-building strategy in full force. Over the past year, it has established close partnerships with over 40 securities research institutes and data service providers, jointly exploring service standards for the Agent era and incremental business models under the token economy. In this process, the participation of strategic investors will provide solid industrial resource support for this collaborative network. "The future society will be a collaborative community based on value networks, rich and diverse. Products and services are rapidly fluid; only through originality and differentiation can enterprises find a path forward, and only through vertical and horizontal linkages can industries accelerate transformation," Li further emphasized.
Alex Zhou, Managing Partner of Qiming Venture Partners, stated: "Over the past half year, AI has made notable breakthroughs across five directions: better thinking (reasoning capability), better doing (AI agents), seeing and hearing (multimodality), lower cost (declining token costs), and local operation (on-device small models). Qiming Venture Partners believes 2026 will be the breakout year for vertical domain AI applications. The financial industry boasts massive market scale, solid data foundations, high labor costs, and has historically been an early adopter of new technologies — making it the optimal track for vertical AI deployment. Xuntuo Technology, with outstanding commercial judgment and execution, has precisely positioned itself for this opportunity and already serves multiple top-tier financial institutions. Its AlphaPai product, built on data moats plus deep workflow integration, has become core AI infrastructure for daily financial operations, leading in penetration among domestic peers."
This funding round was co-led by Qiming Venture Partners, HSG, and Hillhouse, with Gf Qianhe Investment and CITIC Capital's private equity arm CITIC Capital (信宸资本) following on to enable industrial synergies, while existing investors Eastern Bell Capital and Future Capital continued to increase their stakes. China Renaissance served as the company's exclusive financial advisor.
PAST COVERAGE
Qiming Perspectives | Three AI IPOs to Start the Year: A Conversation with Alex Zhou on Following Power Laws and Firmly Backing Technology Targets in Long, Deep Slopes and Large Tracks Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Companies Vol.10, 2026.3.24 Qiming Perspectives | Duane Kuang: Over the Next 20 Years, Investing in AI Is China's Greatest Investment Certainty
Qiming Venture Partners was founded in 2006. The firm currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since inception, it has focused on investing in outstanding early and growth-stage companies in Technology and Healthcare innovation.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have listed on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential companies in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 0800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), SinoCellTech (688520.SH), Insilico Medicine (03696.HK), Hoba Therapeutics, Yuanxin Technology, MediLink Therapeutics, LaNova Medicines, StepFun, and others.